Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib.

Sandhu, Sunny; Chaudhry, Hunza; Zhang, Sharon; Prajapati, Devang

Sandhu, Sunny; Chaudhry, Hunza; Zhang, Sharon; Prajapati, Devang.

Afiliación

Sandhu S; Department of Internal Medicine, University of California, San Francisco- Fresno, Fresno, CA, USA.
Chaudhry H; Department of Internal Medicine, University of California, San Francisco- Fresno, Fresno, CA, USA.
Zhang S; Department of Pathology, Community Medical Centers, Fresno, CA, USA.
Prajapati D; Department of Gastroenterology & Hepatology, University of California, San Francisco- Fresno, Fresno, CA, USA.

Case Reports Hepatol ; 2022: 9630996, 2022.

Article en En | MEDLINE | ID: mdl-35669160

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Case Reports Hepatol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google